BNP Paribas Financial Markets’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $202K | Buy |
22,823
+5,372
| +31% | +$47.5K | ﹤0.01% | 2965 |
|
|
2025
Q1 | $137K | Sell |
17,451
-5,841
| -25% | -$45.7K | ﹤0.01% | 3084 |
|
|
2024
Q4 | $245K | Buy |
+23,292
| New | +$245K | ﹤0.01% | 2923 |
|
|
2024
Q2 | – | Sell |
-4,469
| Closed | -$75.5K | – | 3360 |
|
|
2024
Q1 | $75.5K | Buy |
4,469
+1,685
| +61% | +$28.5K | ﹤0.01% | 2834 |
|
|
2023
Q4 | $39.3K | Buy |
2,784
+1,625
| +140% | +$22.9K | ﹤0.01% | 2890 |
|
|
2023
Q3 | $11.9K | Sell |
1,159
-7,347
| -86% | -$75.7K | ﹤0.01% | 2930 |
|
|
2023
Q2 | $140K | Buy |
8,506
+7,989
| +1,545% | +$132K | ﹤0.01% | 2527 |
|
|
2023
Q1 | $4.74K | Buy |
517
+73
| +16% | +$669 | ﹤0.01% | 2952 |
|
|
2022
Q4 | $3.18K | Buy |
+444
| New | +$3.18K | ﹤0.01% | 3035 |
|
|
2022
Q3 | – | Sell |
-3,298
| Closed | -$8.05K | – | 4023 |
|
|
2022
Q2 | $8.05K | Buy |
+3,298
| New | +$8.05K | ﹤0.01% | 3133 |
|
|
2015
Q4 | – | Sell |
-2
| Closed | -$33 | – | 3574 |
|
|
2015
Q3 | $33 | Buy |
+2
| New | +$33 | ﹤0.01% | 3602 |
|